Kopfschmerz

  • Th. Brandt
  • S. Förderreuther

Zusammenfassung

Man unterteilt Kopf- und Gesichtsschmerzen in solche, die in der Regel keine Strukturläsionen aufweisen, jedoch eine organische Ursache haben (Primäre Kopf- und Gesichtsschmerzen) und solche mit Strukturläsionen (sekundäre oder symptomatische Kopf- und Gesichtsschmerzen). Symptomatische Kopfschmerzen müssen in erster Linie beim erstmaligen Auftreten heftiger Kopfschmerzen ausgeschlossen werden (z. B. Blutung, Sinusvenenthrombose, Meningitis, Glaukom, hypertensive Krise etc.). Durch eine strukturierte Anamneseerhebung und eine eingehende körperliche Untersuchung können nahezu alle Patienten diagnostisch eingeordnet werden. (Übersicht 75.1; [26])

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Andersson KE, Vinge E (1990) Beta-adrenoceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine. Drugs 39: 355–373PubMedCrossRefGoogle Scholar
  2. 2.
    Andersson PG (1975) Ergotamin headache. Headache 15: 118PubMedCrossRefGoogle Scholar
  3. 3.
    Antonaci F, Sjaastad O (1989) Chronic paroxysmal hemicrania: A review of the clinical manifestations. Headache 29: 648–656Google Scholar
  4. 4.
    Brandt T, Peatfield RC (1996) Cluster headache and chronic paroxysmal hemicrania. In: Brandt T, Caplan LR, Dichgans J, Diener HC, Kennard C (eds) Neurological disorders: course and treatment. Academic press, pp 17–27Google Scholar
  5. 5.
    Brown JA, Preul MC (1989) Percutaneous trigeminal ganglion compression for trigeminal neuralgia. J Neurosurg 70: 900–904PubMedCrossRefGoogle Scholar
  6. 6.
    Buzzi MG, Bonamini M, Moskowitz MA (1995) Neurogenic model of migraine. Cephalalgia 15: 277–280PubMedGoogle Scholar
  7. 7.
    Buzzi MG, Moskowitz MA (1990) The antimigraine drug, sumatriptan (GR 43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 99: 202–206PubMedCrossRefGoogle Scholar
  8. 8.
    Canavero S, Bonicalzi V, Ferroli P, Zeme S, Montalenti E, Benna P (1995) Lamotrigine control of idiopathic trigeminal neuralgia [letter].J Neurol Neurosurg Psychiatry 59: 646CrossRefGoogle Scholar
  9. 9.
    Diener HC, Feldmann E (1996) Side Effects of drug therapy in neurology. In: Brandt T, Caplan LR, Dichgans J, Diener HC, Kennard C (eds) Neurological disorders: course and treatment. Academic press, pp 1069–1084Google Scholar
  10. 10.
    Diener HC, Brune K, Gerber W-D, Göbel H, Pfaffenrath V (1997) Behandlung der Migräneattacke and Migäneprophylaxe. Deutsches Ärzteblatt 94: A-3092–3102 (Heft 46 ).Google Scholar
  11. 11.
    Diener HC, Dichgans J, Scholz E, Geiselhart S, Gerber W-D, Bille A (1989) Analgesic-induced chronic headache: longterm results with withdrawal therapy. J Neurol 236: 9–14PubMedCrossRefGoogle Scholar
  12. 12.
    Diener HC, Föh M, Iaccarino C, Wessely P, Isler H, Strenge H, Fischer M, Wedekind W, Taneri Z on behalf of the study group (1996) Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. Cephalalgia 16: 441–447PubMedCrossRefGoogle Scholar
  13. 13.
    Diener HC, Gendolla A, Limmroth V (1996) Valproinsäure in der Migräneprophylaxe. Akt Neurol 23: 265–268CrossRefGoogle Scholar
  14. 14.
    Dieterich M, Brandt T (1985) Is obligatory bed rest after lumbar puncture obsolete? Eur Arch Psychiatr Neurol Sci 235: 71–75CrossRefGoogle Scholar
  15. 15.
    Dieterich M, Brandt T (1988) Incidence of post-lumbar puncture headache is independent of daily fluid intake. Eur Arch Psychiatr Neurol Sci 237: 194–196CrossRefGoogle Scholar
  16. 16.
    Edvinsson C, Goadsby PJ (1994) Neuropeptides in migraine and cluster headache. Cephalalgia 14: 320–327PubMedCrossRefGoogle Scholar
  17. 17.
    Ferrari MD, Saxena PR (1995) 5-HT1 receptors in migraine pathophysiology and treatment. Europ J Neurol 2: 5–21Google Scholar
  18. 18.
    Fogelholm R, Murros K (1992) Tizanidine in chronic tension type headache. A placebo controlled double-blind cross-over study. Headache 32: 509–513Google Scholar
  19. 19.
    Fromm GH (1989) Trigeminal neuralgia and related disorders. Neurol Clin 7:3o5–319Google Scholar
  20. 20.
    Gerber WD (1986) Verhaltensmedizin der Migräne. VCH, WeinheimGoogle Scholar
  21. 21.
    Goadsby PJ, Lipton RB (1997) A review of paroxysmal hemicranias, SUNCT syndrome and other short lasting headaches with autonomic feature, including new cases. Brain 120: 193–209Google Scholar
  22. 22.
    Göbel H (1997) Kopfschmerz durch Einwirkung von Substanzen oder deren Entzug. In: Göbel H (Hrsg) Die Kopfschmerzen. Springer Verlag, Berlin Heidelberg New York Tokyo, S 621–636Google Scholar
  23. 23.
    Göbel H, Hamouz V, Hansen C, Heininger K., Hirsch S, Lindner V, Heuss D, Soyka D (1994) Amitriptylin in der Therapie des chronischen Kopfschmerz vom Spannungstyp. Nervenarzt 65: 670–679PubMedGoogle Scholar
  24. 24.
    Göbel H, Schmidt G, Soyka D (1994): Effect of peppermint and eucalyptus oil preparations on neurophysiological and experimental algesimetric headache parameters. Cephalalgia 14: 228–234PubMedCrossRefGoogle Scholar
  25. 25.
    Green MW, Selman JE (1991) Review article: the medical management of trigeminal neuralgia. Headache 31: 588–592PubMedCrossRefGoogle Scholar
  26. Headache Classification Committee of the International Headache Society, Olesen J et al. (1988) Classification und diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8 [Suppl 71: 9–73Google Scholar
  27. 27.
    Jannetta PJ (1985) Microsurgical management of trigeminal neuralgia. Arch Neurol 42: 800–801PubMedCrossRefGoogle Scholar
  28. 28.
    Kudrow L (1982) Paradoxical effect of frequent analgesic use. In: Critchley M (ed) Adv Neurol 33: 335–341Google Scholar
  29. 29.
    Langemark M, Bach FW, Jensen TS, Olesen J (1993) Decreased nociceptive flexion reflex threshold in chronic tension-type headache. Arch Neurol. 50: 1061–1064PubMedCrossRefGoogle Scholar
  30. 30.
    Lauritzen M (1994) Pathophysiology of the migraine aura. The spreading depression theory. Brain 117: 199–210PubMedCrossRefGoogle Scholar
  31. 31.
    Lechin F, Dijs B van der, Lechin ME, Amat J, Lechin AE, Cabrera A, Gómes F, Acosta E, Arocha L, Villa S, Jiménez V (1989) Pimozide therapy for trigeminal neuralgia. Arch Neurol 46:96o - 963Google Scholar
  32. 32.
    Magni G (1991) The use of antidepressants in the treatment of chronic pain. A review of the current evidence. Drugs 42: 730–748PubMedCrossRefGoogle Scholar
  33. 33.
    Mairs AP, Stewart TJ (1990) Surgical treatment of glosso-pharyngeal neuralgia via pharyngeal approach. J Laryngol Otol 104: 12–16PubMedCrossRefGoogle Scholar
  34. 34.
    Mathew NT (1990) Drug-induced headache. Neurol Clin 8: 903–912PubMedGoogle Scholar
  35. 35.
    Mathew NT (1992) Cluster headache. Neurology 42 (Suppl. 2): 22–31PubMedGoogle Scholar
  36. 36.
    Meyler WJ (1995) Side effects of ergotamine. Cephalalgia 16: 5–10CrossRefGoogle Scholar
  37. 37.
    Olesen J, Diener HC Tension-type and cervicogenic headache. In:Brandt T, Caplan LR, Dichgans J, Diener HC, Kennard C (eds) Neurological disorders: course and treatment. Academic press, pp 29–35Google Scholar
  38. 38.
    Ophoff RA, Terwindt G, Verguowe N, vEijk R, Oefner PJ, Hoffman SMG, Lamerdin JE, Mohrenweiser HE, Bulman DE., Ferrari M, Haan J, Lindhout D, vOmmen G-JB, Hofker MH, Ferrari MD, Frants RR (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca’ channel gene CACNL1A4. Cell 87: 543–552PubMedCrossRefGoogle Scholar
  39. 39.
    Pfaffenrath V, Pöllmann W, Kufner G, Drubba S (1985) Migräne and /3-Blocker. Fortschr Neurol Psychiatr 53: 13–21PubMedCrossRefGoogle Scholar
  40. 40.
    Pfaffenrath V, Wermuth A, Pöllmann W (1988) Der Spannungskopfschmerz–Eine Ubersicht. Fortschr Neurol Psychiatr 56: 403–418CrossRefGoogle Scholar
  41. 41.
    Pöllmann W, Keidel M, Pfaffenrath V (1996) Kopfschmerzen and die Halswirbelsäule. Nervenarzt 67: 821–836PubMedCrossRefGoogle Scholar
  42. 42.
    Ramadan NM (1996) Headache caused by raised ICP and intracranial hypotension. Curr Opin Neurol 9: 214–218PubMedCrossRefGoogle Scholar
  43. 43.
    Russel MB, Olesen J (1996) A nosographic analysis of the migraine aura in a general population. Brain 119: 355–361CrossRefGoogle Scholar
  44. 44.
    Schoenen J, Bottin D, Hardy F, Gerard P (1991) Cephalic and extracephalic pressure pain thresholds in chronic tension-type headache. Pain 47: 145–149PubMedCrossRefGoogle Scholar
  45. 45.
    Sekul EA, Cupler EJ, Dalakas MC(1994) Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med 121: 259–262Google Scholar
  46. 46.
    Silberstein SD (1993) Tension-type and chronic daily headache. Neurology 43: 1644–1649PubMedCrossRefGoogle Scholar
  47. 47.
    Silberstein SD, Marcelis J (1992) Headache associated with changes in intracranial pressure. Headache 32: 84–94PubMedCrossRefGoogle Scholar
  48. 48.
    Sjaastad 0 (1988) Cluster headache: The possible significance of midline structures. Cephalalgia 8: 229–236CrossRefGoogle Scholar
  49. 49.
    Sjaastad O, Dale I (1974) Evidence vor a new (?), treatable headache entity. Headache 14: 105–108PubMedCrossRefGoogle Scholar
  50. 50.
    Sjaastad O, Saunte C, Hovdahl H, Breivik H, Gronbaek E (1983) Cervicogenic headache. An hypothesis. Cephalalgia 3: 249–256Google Scholar
  51. 51.
    Sorensen AG, Lutrer FM, Moskowitz MA, Rosen BR (1996) Investigation of spontaneous migraine aura in humans using functional MRI. Proceedings of the International Society for Magnetic Resonance in Medicine, 4th Annual Meeting and Exhibition New York 1: 282Google Scholar
  52. 52.
    Steiger HJ (1991) Prognostic factors in the treatment of trigeminal neuralgia. Analysis of a differential therapeutic approach. Acta Neurochir (Wien) 113: 11–17CrossRefGoogle Scholar
  53. 53.
    Stovner LJ, Sjaastad 0 (1995) Treatment of cluster headache and its variants. Curr Opin Neurol 8: 243–247Google Scholar
  54. 54.
    Strupp M, Brandt T (1997) Should one reinsert the stylet during lumbar puncture? N Engl J Med 336: 1190PubMedCrossRefGoogle Scholar
  55. 55.
    Visser WH, de Vried RHM, Jaspers NMWH, Ferrari MD (1996) Sumatriptan in clinical practice: A 2-year review of 453 migraine patients. Neurology 47: 46–51PubMedCrossRefGoogle Scholar
  56. 56.
    Weiller C, May A, Limmroth V, Jüptner M, Kaube H, vSchayck R, Coenen HH, Diener HC (1995) Brain stem activation in spontanous human migraine attacks. Nature Med 7: 658–9660Google Scholar
  57. 57.
    Woods R, Iacoboni M, Mazziotta JC (1994) Bilateral spreading cerebral hypoperfusion during spontanous migraine headache. N Engl J Med 331: 1689–1692PubMedCrossRefGoogle Scholar
  58. 58.
    Young RF (1988) Glycerol rhizolysis for treatment of trigeminal neuralgia. J Neurosurg 69: 39–45PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • Th. Brandt
  • S. Förderreuther

There are no affiliations available

Personalised recommendations